BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aihara Y, Yoshiji H, Yamazaki M, Ikenaka Y, Noguchi R, Morioka C, Kaji K, Tastumi H, Nakanishi K, Nakamura M, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Fujimoto M, Uemura M, Fukui H. A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma. World J Gastrointest Oncol 2012; 4(5): 115-118 [PMID: 22645635 DOI: 10.4251/wjgo.v4.i5.115] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Choi SW, Lee JM, Kim DG, Noh MH. [Acute Acalculous Cholecystitis Associated with Sunitinib Treatment for Renal Cell Carcinoma]. Korean J Gastroenterol 2020;75:103-7. [PMID: 32098465 DOI: 10.4166/kjg.2020.75.2.103] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Clark Gamblin T, Turaga KK. Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis. Ann Surg Oncol. 2014;21:240-247. [PMID: 24114054 DOI: 10.1245/s10434-013-3300-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
3 Honda S, Saito Y, Sawada K, Hasebe T, Nakajima S, Okumura T. Repeated Perforation of the Gallbladder in a Patient with Hepatocellular Carcinoma Receiving Lenvatinib. Intern Med 2020;59:657-62. [PMID: 31735795 DOI: 10.2169/internalmedicine.3806-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Pappas S, Gamblin TC, Turaga KK. Management of acute cholecystitis in cancer patients: a comparative effectiveness approach. Surg Endosc 2014;28:1505-14. [DOI: 10.1007/s00464-013-3344-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]